{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:23:37Z","timestamp":1790771017988,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,20]]},"DOI":"10.1097\/qad.0b013e3283081e08","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T21:47:33Z","timestamp":1236289653000},"page":"1539-1549","source":"Crossref","is-referenced-by-count":38,"title":["Peroxisome proliferator-activated receptor-\u03b3 activation suppresses HIV-1 replication in an animal model of encephalitis"],"prefix":"10.1097","volume":"22","author":[{"given":"Raghava","family":"Potula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servio H","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Knipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Leibhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Schall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Heilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Morsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Papugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Persidsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.0503205","article-title":"Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection","volume":"74","author":"Persidsky","year":"2003","journal-title":"J Leukoc Biol"},{"key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"R3-2-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ppul.20338","article-title":"Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?","volume":"41","author":"Denning","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"R6-2-20210130","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1073\/pnas.95.13.7614","article-title":"Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein","volume":"95","author":"Ricote","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.175.8.4948","article-title":"Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients","volume":"175","author":"Klotz","year":"2005","journal-title":"J Immunol"},{"key":"R8-2-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Exp Neurol"},{"key":"R9-2-20210130","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.2174\/092986705774462923","article-title":"Therapeutic targets in inflammatory disease","volume":"12","author":"Hume","year":"2005","journal-title":"Curr Med Chem"},{"key":"R10-2-20210130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem"},{"key":"R11-2-20210130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(01)00285-5","article-title":"Amelioration of experimental autoimmune encephalomyelitis in C57BL\/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma","volume":"116","author":"Niino","year":"2001","journal-title":"J Neuroimmunol"},{"key":"R12-2-20210130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jnr.10501","article-title":"Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation","volume":"71","author":"Kielian","year":"2003","journal-title":"J Neurosci Res"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1523\/JNEUROSCI.3987-04.2004","article-title":"Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide","volume":"24","author":"Camacho","year":"2004","journal-title":"J Neurosci"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"16913","DOI":"10.1074\/jbc.M200875200","article-title":"Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and posttranscriptional effects","volume":"277","author":"Hayes","year":"2002","journal-title":"J Biol Chem"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200209010-00001","article-title":"Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects","volume":"31","author":"Skolnik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-2-20210130","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1182\/blood-2005-04-1403","article-title":"Inhibition of Indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in animal model of HIV-1 encephalitis","volume":"106","author":"Potula","year":"2005","journal-title":"Blood"},{"key":"R18-2-20210130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2353\/ajpath.2006.051181","article-title":"Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis","volume":"168","author":"Potula","year":"2006","journal-title":"Am J Pathol"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1084\/jem.167.4.1428","article-title":"Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes","volume":"167","author":"Gendelman","year":"1988","journal-title":"J Exp Med"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.4049\/jimmunol.180.3.1854","article-title":"Activation of peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes","volume":"180","author":"Ramirez","year":"2008","journal-title":"J Immunol"},{"key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00041433-200206000-00011","article-title":"Roles of peroxisome proliferator-activated receptor gamma in lipid homeostasis and inflammatory responses of macrophages","volume":"13","author":"Klappacher","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J Biol Chem"},{"key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1194\/jlr.M500504-JLR200","article-title":"Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics","volume":"47","author":"Lemay","year":"2006","journal-title":"J Lipid Res"},{"key":"R24-2-20210130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"R25-2-20210130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1189\/jlb.0403180","article-title":"Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells","volume":"74","author":"Rohr","year":"2003","journal-title":"J Leukoc Biol"},{"key":"R26-2-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-4690-1-13","article-title":"HIV-1 gene expression: lessons from provirus and nonintegrated DNA","volume":"1","author":"Wu","year":"2004","journal-title":"Retrovirology"},{"key":"R27-2-20210130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/nar\/28.3.663","article-title":"A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter","volume":"28","author":"Pereira","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R28-2-20210130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.193.8.905","article-title":"Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS","volume":"193","author":"Williams","year":"2001","journal-title":"J Exp Med"},{"key":"R29-2-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1568010042634578","article-title":"PPARs as drug targets to modulate inflammatory responses?","volume":"3","author":"Genolet","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"R30-2-20210130","first-page":"323","article-title":"Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis","volume":"23","author":"Okamoto","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R31-2-20210130","first-page":"142","article-title":"Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation","volume":"50","author":"Hisada","year":"2005","journal-title":"Rocz Akad Med Bialymst"},{"key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/en.2004-1046","article-title":"Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB","volume":"146","author":"Fan","year":"2005","journal-title":"Endocrinology"},{"key":"R33-2-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biocel.2004.08.008","article-title":"Ciglitazone induces early cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells through p65 phosphorylation","volume":"37","author":"Chen","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"R34-2-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: inflammation, NF-kappaB and PPAR","volume":"544","author":"Vanden Berghe","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"R35-2-20210130","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jcb.10668","article-title":"Phosphorylation of PPARgamma via active ERK1\/2 leads to its physical association with p65 and inhibition of NF-kappabeta","volume":"90","author":"Chen","year":"2003","journal-title":"J Cell Biochem"},{"key":"R36-2-20210130","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"R37-2-20210130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-gamma agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Curr Pharm Des"},{"key":"R38-2-20210130","doi-asserted-by":"crossref","first-page":"14747","DOI":"10.1074\/jbc.M210819200","article-title":"15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia","volume":"278","author":"Park","year":"2003","journal-title":"J Biol Chem"},{"key":"R39-2-20210130","first-page":"29","article-title":"Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys","volume":"47","author":"Maeshiba","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"R40-2-20210130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.ATV.0000103951.67680.B1","article-title":"Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis","volume":"24","author":"Ricote","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R41-2-20210130","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"R42-2-20210130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"R43-2-20210130","doi-asserted-by":"crossref","first-page":"34176","DOI":"10.1074\/jbc.M203436200","article-title":"Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"R44-2-20210130","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1074\/jbc.275.7.4541","article-title":"Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT","volume":"275","author":"Yang","year":"2000","journal-title":"J Biol Chem"},{"key":"R45-2-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI11918","article-title":"Hostile takeovers: viral appropriation of the NF-kappaB pathway","volume":"107","author":"Hiscott","year":"2001","journal-title":"J Clin Invest"},{"key":"R46-2-20210130","doi-asserted-by":"crossref","first-page":"25573","DOI":"10.1074\/jbc.273.40.25573","article-title":"Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages","volume":"273","author":"Chinetti","year":"1998","journal-title":"J Biol Chem"},{"key":"R47-2-20210130","doi-asserted-by":"crossref","first-page":"32681","DOI":"10.1074\/jbc.M002577200","article-title":"Oxidized low-density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B","volume":"275","author":"Chung","year":"2000","journal-title":"J Biol Chem"},{"key":"R48-2-20210130","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pbio.0030076","article-title":"A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation","volume":"3","author":"Barboric","year":"2005","journal-title":"PLoS Biol"},{"key":"R49-2-20210130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biochi.2004.11.010","article-title":"Phosphorylation of PPARs: from molecular characterization to physiological relevance","volume":"87","author":"Diradourian","year":"2005","journal-title":"Biochimie"},{"key":"R50-2-20210130","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/mol.105.012260","article-title":"Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling","volume":"68","author":"Gardner","year":"2005","journal-title":"Mol Pharmacol"},{"key":"R51-2-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/toxsci\/kfj062","article-title":"The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR)","volume":"90","author":"Peraza","year":"2006","journal-title":"Toxicol Sci"},{"key":"R52-2-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R53-2-20210130","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.168.8.3941","article-title":"Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis","volume":"168","author":"Poluektova","year":"2002","journal-title":"J Immunol"},{"key":"R54-2-20210130","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JVI.66.6.3883-3887.1992","article-title":"Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription","volume":"66","author":"Liu","year":"1992","journal-title":"J Virol"},{"key":"R55-2-20210130","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1128\/JVI.75.18.8524-8537.2001","article-title":"Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation","volume":"75","author":"West","year":"2001","journal-title":"J Virol"},{"key":"R56-2-20210130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/088922200309412","article-title":"Occurrence of additional NF-kappaB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates","volume":"16","author":"Hunt","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R57-2-20210130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","article-title":"HIV-associated cognitive impairment before and after the advent of combination therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J Neurovirol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200808200-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:06:35Z","timestamp":1618038395000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200808200-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,20]]},"references-count":57,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283081e08","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8,20]]}}}